Swietenia humilis
Swietenia humilis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Swietenia humilis is a botanical species that has gained significant attention for its potential therapeutic properties. Research indicates that the seeds of this plant possess notable antihyperglycemic activities. These biological effects make it a subject of interest for managing metabolic health, particularly in relation to Type 2 Diabetes. By targeting blood glucose regulation, the plant offers a natural avenue for exploring alternative dietary interventions. Consequently, studying its chemical composition is essential for understanding its role in modern diabetes management.
- Synonyms
- Swietenia Multijuga · Swietenia Cirrhata · 1 more
- Common names
- Not available
- Family
- Meliaceae
- Distribution
- Not available
- Plant Parts
- Seed
Classification
Common Names
Swietenia humilis is a versatile species recognized by a diverse array of regional common names. It is most frequently referred to simply as Caoba, though its identity shifts depending on its specific geographic origin. In certain areas, it is known as Caoba De Honduras or as the distinct Caoba De Pacifico. Variations in nomenclature also include the name Caoba del Pacífico to reflect its coastal associations. Furthermore, the plant is sometimes identified locally by the name Coabilla.
Sources: Catalogue of Life (COL)
Synonyms
Swietenia humilis is a botanical species characterized by a complex history of taxonomic classifications. Throughout various scientific studies, this plant has been associated with several different names. Specifically, it is recognized as having Swietenia bijuga as a synonym. Furthermore, researchers have also linked it to the synonyms Swietenia cirrhata and Swietenia multijuga. Understanding these overlapping identities is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Swietenia humilis is a distinctive member of the kingdom Plantae. This species is classified under the class Equisetopsida, showcasing its fundamental botanical structure. Within the biological hierarchy, it belongs to the order Sapindales. It is further categorized into the genus Swietenia, which defines its close evolutionary relatives. Finally, this plant is a proud representative of the Meliaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Meliaceae |
| Genus | Swietenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Swietenia humilis maintains a widespread presence across various regions of North America, with a particular concentration throughout Mexico. Its distribution spans the diverse landscapes of Central Mexico and extends into the coastal reaches of the Gulf region. The species is also found throughout the Northeast and Southeast portions of the country. Additionally, its natural range reaches into the Northwest, showcasing remarkable ecological versatility. This extensive geographic reach highlights the plant's ability to thrive in many different Mexican environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Swietenia humilis is a self-supporting plant characterized by its distinct tree growth form. This species typically reaches a maximum height of approximately 15 meters in many environments. However, under optimal conditions, it can grow even taller, reaching a height of up to 20 meters. This structural versatility allows the tree to establish a significant presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Swietenia humilis has demonstrated significant antihyperglycemic activity, supporting its traditional use in Mexico for treating type 2 diabetes. This therapeutic effect is primarily attributed to a class of tetranortriterpenoids known as mexicanolides found within the plant's seeds. Scientific investigations reveal that these compounds work through multi-target mechanisms involving the pancreas, liver, and skeletal muscle. Specifically, they influence insulin secretion, inhibit glucose-6-phosphatase, and enhance glucose uptake to help regulate blood sugar levels. Because of these diverse pharmacological actions, this species represents a promising natural resource for managing glucose homeostasis.
Compounds
Conditions
Swietenia humilis seeds are traditionally consumed in Mexico to treat type 2 diabetes due to their significant antihyperglycemic effects. This therapeutic potential is primarily driven by tetranortriterpenoids known as mexicanolides, which target multiple physiological pathways. These compounds work by interacting with pharmacological targets in the pancreas, liver, and skeletal muscle to effectively modulate glucose homeostasis. Specifically, mexicanolides promote insulin secretion, inhibit glucose-6-phosphatase, and enhance glucose uptake in muscle cells. Consequently, the plant serves as a promising natural resource for the medicinal management of type 2 diabetes.
Preparations
Parts used
Swietenia humilis holds significant medicinal value in Mexico, where its seeds are traditionally consumed to manage type 2 diabetes. Scientific investigations have revealed that these seeds contain bioactive compounds known as mexicanolides, which exhibit potent antihyperglycemic effects. These specific metabolites work through multi-target mechanisms that influence the pancreas, liver, and skeletal muscle to regulate glucose levels. By modulating insulin secretion and enhancing glucose uptake, the plant components offer a sophisticated approach to maintaining glucose homeostasis. Consequently, the seed of this species represents a promising natural resource for the development of new antidiabetic treatments.